Fatal drug-drug interaction of brivudine and capecitabine.
Rätz Bravo
Alexandra E
AE
Hofer
Silvia
S
Krähenbühl
Stephan
S
Ludwig
Christian
C
D016907:Adverse Drug Reaction Reporting Systems; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism* / Q000493:pharmacokinetics; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism* / Q000493:pharmacokinetics; D001973:Bromodeoxyuridine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000150:complications / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics; D006562:Herpes Zoster / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D013557:Switzerland
D000964:Antimetabolites, Antineoplastic; D000998:Antiviral Agents; D003841:Deoxycytidine; C020235:brivudine; D000069287:Capecitabine; D001973:Bromodeoxyuridine; D005472:Fluorouracil